Learn how heat wraps treat fibromyalgia pain
Peyronies disease may be even more widespread because many people may feel too embarrassed to talk about it with a healthcare provider
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
Liepinsh, Risks and benefits of carnitine supplementation in diabetes, Exp Clin Endocrinol Diabetes, Fev 2015, 123(2):95-100
We focus on "The BUBS Way," which means prioritizing the fundamentals: quality sleep, real food, consistent movement, and a sense of purpose